NVCR - NovoCure Limited

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 59.32B
Enterprise Value 39.08B
Trailing P/E N/A
Forward P/E 1220.86
PEG Ratio (5 yr expected) 1-8.22
Price/Sales (ttm)31.66
Price/Book (mrq)58.48
Enterprise Value/Revenue 330.84
Enterprise Value/EBITDA 6-797.24

Trading Information

Stock Price History

Beta (3Y Monthly) 2.19
52-Week Change 3156.42%
S&P500 52-Week Change 30.90%
52 Week High 396.31
52 Week Low 326.02
50-Day Moving Average 376.08
200-Day Moving Average 356.95

Share Statistics

Avg Vol (3 month) 3786.4k
Avg Vol (10 day) 3760.5k
Shares Outstanding 595.77M
Float 78.18M
% Held by Insiders 119.58%
% Held by Institutions 166.21%
Shares Short (Jul 31, 2019) 45.28M
Short Ratio (Jul 31, 2019) 46.28
Short % of Float (Jul 31, 2019) 47.27%
Short % of Shares Outstanding (Jul 31, 2019) 45.38%
Shares Short (prior month Jun 28, 2019) 44.24M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin -13.84%
Operating Margin (ttm)-6.28%

Management Effectiveness

Return on Assets (ttm)-3.23%
Return on Equity (ttm)-30.07%

Income Statement

Revenue (ttm)294.45M
Revenue Per Share (ttm)3.12
Quarterly Revenue Growth (yoy)41.00%
Gross Profit (ttm)168.37M
EBITDA -11.39M
Net Income Avi to Common (ttm)-40.74M
Diluted EPS (ttm)-0.43
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)284.58M
Total Cash Per Share (mrq)2.9
Total Debt (mrq)164.87M
Total Debt/Equity (mrq)103.76
Current Ratio (mrq)5.03
Book Value Per Share (mrq)1.62

Cash Flow Statement

Operating Cash Flow (ttm)27.2M
Levered Free Cash Flow (ttm)38.74M